It's a drug that's obviously important to the MS community, and the committee advised us to help get it out there. What we need to do is take into account all of the committee's recommendations, and reach our own conclusions about what various critical components of a risk-management program will have to be included. There are a number of details to be worked out, and we will have to do that very rapidly.
Robert Temple